Emcure Pharmaceuticals Limited

Top buyer Axis Mutual Fund, +0.00% of equity. Top seller Nippon India Mutual Fund, −0.10% of equity. Index and arbitrage funds hidden.

FPI category I + II, % of total shares · 1 named at 1% or more

FPIs named at 1% or more on 30 Jun 2026: Government Pension Fund Global 1.05%.

of promoter holding · 0.03% of total shares

Promoters had pledged 60,000 of their 14.76 cr shares on 30 Jun 2026; 60,000 encumbered in all (pledge, NDU and other).

percentile 100 of 30 days collected

4,760 shares, under 0.01% of equity in SLBS open positions at the end of 25 Sep 2026; that day sits at percentile 100 of 30 days collected. No SLBM trades in EMCURE on 25 Sep 2026.

percentile 14 of 29 days collected · ₹14.6 cr financed

82,707 shares, 0.04% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 14 of 29 days collected.

20-day average 50.9% · percentile 43 of 30 days collected

51.9% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 50.9%; that day sits at percentile 43 of 30 days collected.

EMCURE has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed EMCURE under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.